Global Hemostats Market Growth 2025-2031

Global Hemostats Market Growth 2025-2031

The global Hemostats market size is predicted to grow from US$ 3009 million in 2025 to US$ 4298 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.

North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.

In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.

LP Information, Inc. (LPI) ' newest research report, the “Hemostats Industry Forecast” looks at past sales and reviews total world Hemostats sales in 2024, providing a comprehensive analysis by region and market sector of projected Hemostats sales for 2025 through 2031. With Hemostats sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostats industry.

This Insight Report provides a comprehensive analysis of the global Hemostats landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostats portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemostats market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostats and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostats.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemostats market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats

Segmentation by Application:
Prehospital Treatment
Hospital Treatment

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hemostats market?

What factors are driving Hemostats market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hemostats market opportunities vary by end market size?

How does Hemostats break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.